Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of QBM076 in COPD
NCT01972776Phase 2Terminated
- Sponsor
- Novartis
- Start
- Nov 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of qbm-076 in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Nov 2013; status: terminated.
02
Drugs
qbm-076
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01972776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972776.